Clinical trials in cell and gene therapy

A clinical trial is a research study that seeks to determine if a treatment is safe and effective. Advancing new cell and gene therapies from the laboratory into early-phase clinical trials has proven to be a complex task even for experienced investigators. Due to the wide variety of CGT products and their potential applications, a case-by-case assessment is warranted for the design of each clinical trial.

Objectives: Determine the pharmacokinetics of this regimen by the persistence of modified T cells in the blood of these patients, Evaluate the immunogenicity of murine sequences in chimeric anti-CEA Ig TCR, Assess immunologic parameters which correlate with the efficacy of this regimen in these patients, Evaluate, in a preliminary manner, the efficacy of this regimen in patients with CEA bearing tumors.

    Related Conference of Clinical trials in cell and gene therapy

    October 09-10, 2023

    19th Global Summit on Stem Cell & Regenerative Medicine

    Zurich, Switzerland
    October 19-20, 2023

    5th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada
    November 08-09, 2023

    4th Experts Meeting on Plant, Cellular and Molecular Biology

    Budapest, Hungary
    November 08-09, 2023

    6th Global Conference on Cell and Gene Therapy

    Budapest, Hungary
    November 13-14, 2023

    10th World Congress on Epigenetics and Chromosome

    Valencia, Spain
    December 07-08, 2023

    17th International Conference on Genomics & Pharmacogenomics

    San Francisco, USA

    Clinical trials in cell and gene therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in